NZ280455A - Podophyllin and podophyllotoxin derivatives, pharmaceutical compositions - Google Patents

Podophyllin and podophyllotoxin derivatives, pharmaceutical compositions

Info

Publication number
NZ280455A
NZ280455A NZ280455A NZ28045595A NZ280455A NZ 280455 A NZ280455 A NZ 280455A NZ 280455 A NZ280455 A NZ 280455A NZ 28045595 A NZ28045595 A NZ 28045595A NZ 280455 A NZ280455 A NZ 280455A
Authority
NZ
New Zealand
Prior art keywords
podophyllin
pharmaceutical compositions
podophyllotoxin derivatives
podophyllotoxin
derivatives
Prior art date
Application number
NZ280455A
Inventor
Marina Gordaliza
Maria Angeles Castro
Feliciano Arturo San
Corral Jose Maria Miguel Del
Maria Luisa Lopez
Glynn T Faircloth
Original Assignee
Univ Salamanca
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Salamanca filed Critical Univ Salamanca
Publication of NZ280455A publication Critical patent/NZ280455A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/92—Naphthofurans; Hydrogenated naphthofurans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Transplantation (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NZ280455A 1994-11-14 1995-11-13 Podophyllin and podophyllotoxin derivatives, pharmaceutical compositions NZ280455A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9422947A GB9422947D0 (en) 1994-11-14 1994-11-14 Immunosuppressive cyclolignan derivatives

Publications (1)

Publication Number Publication Date
NZ280455A true NZ280455A (en) 1998-09-24

Family

ID=10764358

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ280455A NZ280455A (en) 1994-11-14 1995-11-13 Podophyllin and podophyllotoxin derivatives, pharmaceutical compositions

Country Status (13)

Country Link
US (1) US5739114A (en)
EP (1) EP0711765B9 (en)
JP (1) JPH08225534A (en)
AR (1) AR001767A1 (en)
AU (1) AU3784695A (en)
BR (1) BR9505178A (en)
CA (1) CA2162760A1 (en)
DE (1) DE69531586T2 (en)
ES (1) ES2206481T3 (en)
GB (1) GB9422947D0 (en)
IL (1) IL115982A (en)
NZ (1) NZ280455A (en)
ZA (1) ZA959665B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001024763A2 (en) 1999-10-01 2001-04-12 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
KR100433679B1 (en) * 2000-11-20 2004-06-09 김송배 Novel 4'-demethyl-4'-O-substituted-1-deoxypodophyllotoxin derivatives and geometric isomers thereof, process for the preparation thereof and antitumor agents comprising the same
SE0102168D0 (en) 2001-06-19 2001-06-19 Karolinska Innovations Ab New use and new compounds
WO2009100349A1 (en) * 2008-02-09 2009-08-13 The Trustees Of Columbia University In The City Of New York Analogues of (-)-picropodophyllin, synthesis and uses thereof
AU2009263074A1 (en) * 2008-06-23 2009-12-30 Axelar Ab Use of cyclolignans for the treatment of a hyperactive immune system
WO2014183055A1 (en) 2013-05-10 2014-11-13 M. Alphabet 2, L.L.C. Methods of treating skin conditions using cyclolignan compounds
JOP20190254A1 (en) 2017-04-27 2019-10-27 Pharma Mar Sa Antitumoral compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567253A (en) * 1984-02-03 1986-01-28 Tony Durst 2-Substituted derivatives of podophyllotoxin and etoposide
AU585936B2 (en) * 1984-12-28 1989-06-29 Conpharm A.B. Pharmaceutically active podophyllotoxins
US4644072A (en) * 1985-04-12 1987-02-17 Bristol-Myers Company Intermediates for the production of epipodophyllotoxin and related compounds and processes for the preparation and use thereof

Also Published As

Publication number Publication date
EP0711765A1 (en) 1996-05-15
EP0711765B1 (en) 2003-08-27
IL115982A (en) 1999-10-28
DE69531586T2 (en) 2004-06-24
BR9505178A (en) 1997-10-28
GB9422947D0 (en) 1995-01-04
AR001767A1 (en) 1997-12-10
EP0711765B9 (en) 2004-03-03
DE69531586D1 (en) 2003-10-02
ZA959665B (en) 1996-05-29
ES2206481T3 (en) 2004-05-16
CA2162760A1 (en) 1996-05-15
US5739114A (en) 1998-04-14
IL115982A0 (en) 1996-01-31
JPH08225534A (en) 1996-09-03
AU3784695A (en) 1996-05-23

Similar Documents

Publication Publication Date Title
IL112384A0 (en) Tetracyclic derivatives, their preparation and pharmaceutical compositions containing them
HUP0103406A3 (en) 1h-imidazopyridine derivatives and pharmaceutical compositions thereof
HUP0102711A3 (en) Epothilone derivatives and pharmaceutical compositions containing them and process for preparation the same
HUT74464A (en) 1n-alkyl-n-arylpyrimidinamines and derivatives thereof, and pharmaceutical compositions containing them
IL122212A (en) Rapamycin derivatives, pharmaceutical compositions comprising them and their preparation
IL111002A0 (en) Piperidine derivatives, their preparation and pharmaceutical compositions containing them
HUP0102990A3 (en) Tetrahydroimidazo-naphtyridine derivatives and pharmaceutical compositions thereof
NZ304901A (en) Taxoid derivatives, preparation thereof and pharmaceutical compositions containing same
IL138899A0 (en) Amidene derivatives and pharmaceutical compositions containing the same
IL140862A (en) Thiobenzimidazole derivatives and pharmaceutical compositions containing the same
IL119994A0 (en) 2-oxo- and 2-thio-1,2-dihydroquinolinyl-oxazolidinones their preparation and pharmaceutical compositions containing them
IL143920A0 (en) 3-heteroarylidenyl-2-indolinone derivatives and pharmaceutical compositions containing the same
HUP9802937A3 (en) Benzo[g]quuinoline derivatives, pharmaceutical compositions containing them and their use
HUP0101381A3 (en) Benzofurylpyrone derivatives and pharmaceutical compositions containing them
HUP9904694A3 (en) Spiropyrrolidine derivatives, their use and pharmaceutical compositions containing them
IL113103A0 (en) Piperidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
IL139480A0 (en) Epothilone derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
HUP0103203A3 (en) Azaadamantane derivatives and pharmaceutical compositions thereof
IL137332A (en) Benzothiadiazoles and derivatives, their preparation and pharmaceutical compositions comprising them
IL108703A0 (en) Substituted azolone derivatives, their preparation and pharmaceutical compositions containing them
HUP0105075A3 (en) 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives, their use and pharmaceutical compositions containing them
HUP0102599A3 (en) Artemisinin derivatives, method for the preparation thereof and pharmaceutical compositions containing the same
HUP9801386A3 (en) Indazolecarboxamide derivatives, preparation thereof and pharmaceutical compositions containing them
HUP0003398A3 (en) Novel triptolide derivatives and pharmaceutical compositions thereof
HUP0001940A3 (en) Benzisothiazole derivatives, their use and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
S38A Application for proceedings under section 38 (amendment of specification with leave of commissioner)

Free format text: BY WAY OF DISCLAIMER

S38C Proceedings under section 38 (amendment of specification with leave of commissioner): specification amended